Shanghai Hengrui Pharmaceutical Co., Ltd;Jiangsu Hengrui Medicine Co., Ltd.
发明人:
TIAN, Chenmin,LI, Hao,LIU, Xun
申请号:
AU2018291702
公开号:
AU2018291702A1
申请日:
2018.06.29
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
Provided is a pharmaceutical composition comprising a PCSK9 antibody or an antigen-binding fragment thereof in a histidine buffer. In addition, the pharmaceutical composition may also comprise saccharides and nonionic surfactants.